Asplenia interventions: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Asplenia}}
{{Asplenia}}
{{CMG}}; {{AE}}{{Anum Dilip}}
{{CMG}}; {{AE}}{{Kalpana Giri}}
 
==Overview==
There are no recommended therapeutic interventions for the management of [disease name].
 
OR
 
[name of intervention] is not the first-line treatment option for patients with [disease name]. [name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
 
OR
 
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
 
OR
 
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
 
OR
 
[Name of intervention] is the mainstay of treatment for [disease or malignancy].


==Indications==
==Indications==
Line 28: Line 9:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Up-To-Date]]​
[[Category:Up-To-Date]]
[[Category:Primary care]]
[[Category:Immunology]]
[[Category:Immunology]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]

Latest revision as of 05:10, 10 September 2021